Search Results 7731-7740 of 33584 for oral

1. Robotic surgery - Doctors & Departments - Mayo Clinic

   ... Oral and throat cancer, Salivary gland cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Melanoma, Tonsil cancer, Skin cancer, Squamous cell ...

2. Tailored Antiplatelet Therapy Following PCI - Mayo Clinic

   Patient is receiving chronic oral anticoagulation therapy (i.e., vitamin K antagonist, direct thrombin inhibitor, Factor Xa inhibitor). Concomitant use of ...

3. A Study to Evaluate the Safety and Feasibility of Platelet-rich Plasma to Treat Facetogenic Low Back Pain - Mayo Clinic

   - Current opioid use of greater than 50mg oral morphine milligram equivalents per day. - No advanced imaging (MRI, CT or lumbar x-ray) of the lumbar spine ...

4. Obstructive sleep apnea - Doctors and departments - Mayo Clinic

   Departments that treat this condition. Dental Specialties · Neurology · Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric ...

5. Women's Wellness: Risks of osteoporosis - Mayo Clinic News Network

   Generally speaking, the risk of developing osteoporosis and being more prone to bone fractures depends on your bone health — the size and strength of your bones ...

6. 53-Week Study Evaluating The Safety And Efficacy Of Intra-Articular Injections Of TPX-100 With Mild To Severe Tibio-Femoral Osteoarthritis Of The Knee - Mayo Clinic

   ... (oral contraceptive implant, injectable or indwelling intrauterine device, condom with spermicide or sexual abstinence) while participating in the study.

7. A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES) - Mayo Clinic

   Non-oral systemic corticosteroids: Participants who have received intravenous, intramuscular, or subcutaneous corticosteroids within 4-weeks prior to Visit 2.

8. A Study of the Safety and Effectiveness of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration - Mayo Clinic

   Use of systemic (e.g., oral, intravenous, intramuscular, rectal), or extensive dermal (> 20% total body surface area) corticosteroids within 5 days prior to ...

9. Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations - Mayo Clinic

   ... Oral, implantable, or injectable hormone contraceptives are not considered effective for this study. Any of the following treatments: Chemotherapy within 4 ...

10. Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy - Mayo Clinic

    Participation eligibility · Ability to swallow and retain oral tablets. · Women of childbearing potential and men must agree to use adequate contraception ( ...